CorMedix Inc. acquired the target/assets from selling shareholders in an acquisition. Date of the transaction is not available.
Deal value was 300000000. Sector: Biopharmaceuticals; Location: USA.
On the acquirer side, legal representation details are not available, but the team included Jared Fertman, Andrew Marmer, Theodore Witt, Autri Saha, William Sobel, Jerolynn Liu, Emma Danziger, Akarshana Premanand, Sean Ewen, Marissa Dressor, Qingqing (Chelsea) Zheng.
Generated by AI, original source from - Data is in progress
selling shareholders advisor
Firm name is in progress
Found it useful? Spread the word.
Willkie advises CorMedix on $300 million acquisition of Melinta Therapeutics | The Sponsor - The Sponsor
